CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma

被引：11
|
作者：
Alcázar, JL [1 ]
Miranda, D [1 ]
Unanue, A [1 ]
Novoa, E [1 ]
Alemán, S [1 ]
Madariaga, L [1 ]
机构：
[1] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Obstet & Gynecol, E-31080 Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2004年 / 84卷 / 02期
关键词：
CA-125; optimal cytoreduction; advanced ovarian cancer;
D O I：
10.1016/j.ijgo.2003.10.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] Prognostic Significance of CA-125 in the Management of Patients with Recurrent Epithelial Ovarian Carcinoma Selected for Secondary Cytoreduction
    Mahner, Sven
    Woelber, Linn
    Jung, Sabine
    Eulenburg, Christine Zu
    Ihnen, Maike
    Schwarz, Joerg
    Sehouli, Jalid
    Jaenicke, Fritz
    ANTICANCER RESEARCH, 2009, 29 (07) : 2817 - 2821
  • [22] Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
    Paulsen, T
    Marth, C
    Kærn, J
    Nustad, K
    Kristensen, GB
    Tropé, C
    GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 326 - 330
  • [23] Nadir CA-125 Level Is an Independent Prognostic Factor in Advanced Epithelial Ovarian Cancer
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 244 - 247
  • [24] Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer
    Merlo, Sebastjan
    Besic, Nikola
    Drmota, Eva
    Kovacevic, Nina
    RADIOLOGY AND ONCOLOGY, 2021, 55 (03) : 341 - 346
  • [25] The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery
    Hidayat, Yudi Mulyana
    Winarno, Gatot Nyarumenteng Adhipurnawan
    Tobing, Maringan Diapari Lumban
    Kustiandi, Arieff
    Mantilidewi, Kemala Isnainiasih
    Krisnadi, Sofie Rifayani
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (05) : 739 - 744
  • [26] Clinical Utility of CA-125 for Maintenance Therapy in the Treatment of Advanced Stage Ovarian Carcinoma
    Micha, John P.
    Goldstein, Bram H.
    Rettenmaier, Mark A.
    Brown, John V., III
    John, Cameron R.
    Markman, Maurie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (02) : 239 - 241
  • [27] The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rocconi, Rodney P.
    Matthews, Kellie S.
    Kemper, Meredith K.
    Hoskins, Kelly E.
    Huh, Warner K.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 242 - 245
  • [28] CA-125 AUC as a predictor for epithelial ovarian cancer relapse
    Manoa, Antonio
    Falcao, Amilcar
    Godinho, Isabel
    Santos, Jorge
    Leitao, Fatima
    de Oliveira, Carlos
    Caramona, Margarida
    CANCER BIOMARKERS, 2008, 4 (02) : 73 - 81
  • [29] Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
    Aurélie Pelissier
    Aurélie Roulot
    Béatrice Guéry
    Claire Bonneau
    Dominique Bellet
    Roman Rouzier
    Journal of Ovarian Research, 9
  • [30] Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
    Pelissier, Aurelie
    Roulot, Aurelie
    Guery, Beatrice
    Bonneau, Claire
    Bellet, Dominique
    Rouzier, Roman
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
12345